Fort Lauderdale, FL - (NewMediaWire) - October 14, 2019 - Veritas Farms, Inc. (OTCQB:VFRMD) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to share CEO and Co-Founder Alexander Salgado’s letter to shareholders discussing recent corporate and business developments. The letter reads as follows:Dear Fellow Shareholders,I would like to take this opportunity to explain the rationale behind our recent decision to enact a reverse stock split. This step was not taken lightly and was necessary to reduce the number of outstanding shares and otherwise properly capitalize our Company in order to position us to uplist our stock from the OTCQB to a national securities exchange. In addition, in connection therewith, we have enhanced our corporate governance by expanding our board of directors so that a majority of the board consists of independent directors and by establishing audit, compensation and nominating and corporate governance committees, the members of which are our independent directors. We believe that positioning Veritas Farms for an uplisting of its common stock to a national securities exchange, will be a significant step forward and the culmination of four years of hard effort, all made possible by the support of you, our shareholders.2019 has proven to be a period of significant growth for the Company.We have reported a 500% increase in year to year revenue for the 6 months ended June 30, 2019, from $818,585 in 2018 to $4,496,275 in 2019, and we expect to see continued growth over the balance of this year. This sustained revenue growth has been made possible thanks to an aggressive expansion of our retailer and distributor network. We now count more than 4,500 retailers and distributors as partners within our rapidly expanding network. We expect this trend to continue and for Veritas Farms™ brand products to be stocked on shelves and warehouses around the country and internationally.We have also successfully completed two private placement financings over the past 24 months. This has provided us with an infusion of capital in excess of $20 million. This capital is being deployed to fuel our continued efforts to expand our retailer and distribution network, implement additional sales and marketing platforms, expand our infrastructure, fill key management and administrative positions, and develop several exciting new category and product launches over the remainder of 2019 and beyond.An excellent example of this capital being put to good use is the growth of our 100% owned and operated 140-acre farm and production facility in Pueblo, Colorado. Key enhancements have been made to our farming infrastructure and processes which have increased our 2019 yields by as much as five times compared to our 2018. This will allow us to meet the rapidly rising demand for Veritas Farms™ full spectrum hemp products.We believe the completion of the reverse stock split, enhancements to the Company’s corporate governance, our achievements in expanding Veritas Farms’ business and revenues, and our raising of significant capital to fund operations are all necessary steps in positioning Veritas Farms to uplist its common stock to a national securities exchange.I look forward to sharing more developments with you in the near future.Sincerely,Alexander M. SalgadoCEO and co-FounderAbout Veritas Farms, Inc.Veritas Farms, Inc. (OTCQB:VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids. The Company currently owns and operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers. Veritas Farms™ brand full spectrum hemp oil ...

Qrons is Developing 3D Printable Implants to Treat Penetrating Brain InjuriesNEW YORK, NY - (NewMediaWire) - October 14, 2019 - Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of traumatic brain injuries, including concussions and penetrating injuries, announced today that it has entered into an Intellectual Property License Agreement (the “Agreement”) with Dartmouth College for an exclusive world-wide license of Intellectual Property related to 3D printable materials in the fields of human and animal health. The Agreement provides for the payment by Qrons of initial and annual license fees and royalty payments based upon Qrons' product sales. The Agreement was signed on October 2, 2019 and is effective as of September 3, 2019. Qrons is using the 3D process covered by the patent entitled “Mechanically Interlocked Molecules-based Materials for 3D Printing” as part of its injury specific 3D printable implants to treat penetrating brain injuries. Qrons is also a party to a Sponsored Research Agreement with Dartmouth to advance the license or ownership of additional Intellectual Property. The Qrons research team is working closely with Professor Chenfeng Ke, a member of Qrons Scientific Advisory Board and an inventor of the licensed 3D process, and PhD candidate Qianming Lin. Ido Merfeld, Qrons Co-founder and Head of Product, commented, “The intellectual property covered by this license has been instrumental in helping us advance our research on the treatment of penetrating brain injuries. We believe combining Qrons’ proprietary hydrogel with customizable 3D printing capabilities is an innovative approach to treating traumatic brain injuries, for which there are limited treatments.”Jonah Meer, Qrons’ Co-founder and CEO, added, “We’re excited to have concluded negotiations to acquire an exclusive license for this important intellectual property. There is a great need for our promising treatments, and this technology is an integral part of our work to develop innovative 3D printable, biocompatible advanced materials.”Chenfeng Ke, Assistant Professor of Chemistry, Dartmouth College, stated, “We are excited to partner with Qrons and continue the development of smart hydrogels with 3D printing capability for the treatment of traumatic brain injuries.”Nila Bhakumi, Director of Technology Transfer at Dartmouth, echoed Professor Ke’s comments and added, “We are delighted with Dr. Ke’s collaboration with Qrons as they try to solve the very important problem of Traumatic Brain Injury.”About Dartmouth CollegeFounded in 1769, Dartmouth College is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools - the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.About Qrons Inc. Headquartered in New York City, Qrons is a publicly traded emerging biotechnology company developing advanced stem cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries and concussions. The Company has two product candidates for treating TBIs, both integrating proprietary, modified mesenchymal stem cells ("MSCs") and smart synthetic material, QS100™, an injury specific, 3D printable, implantable MSCs-synthetic hydrogel, to treat penetrating brain injuries and QS200™, an injectable MSCs-synthetic hydrogel for the treatment of diffused injuries commonly referred to as concussions. The Company is a party to a license and research funding agreement and related service agreements with Ariel Scientific Innovations Ltd., a wholly owned subsidiary of Ariel University, based in Ariel, Israel, and in addition to the world-wide exclusive intellectual property license, a Sponsored Research Agreement with Dartmouth ...

JACKSONVILLE, FL - (NewMediaWire) - October 14, 2019 - mCig, Inc. (OTCQB: MCIG) a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, is pleased to announce today the Company will exhibit at MJBizCon on December 11-13, 2019 in Las Vegas, Nevada.The show will provide the Company with the opportunity to further showcase its products, including the CannaPure Ozone unit and innovative LED commercial lights specifically tailored for the cannabis industry.The MJBizCon show is a unique chance for the Company to network with industry executives, learn more about trends in the marketplace, and connect with companies that have similar goals.“We see this conference as an opportunity to increase awareness around MCIG and the CannaPure Ozone Unit, developed in partnership with industry ozone leader Purequest Technology’s. As the cannabis industry becomes more compliant with standard food and pharmaceutical practices our line of ozone solutions will become the standard in every facility in the world,” said Alex Levitsky , CEO of Cannabiz Supply, wholly owned subsidiary of MCIG Inc. MJBizCon is an annual three-day event, where cannabis industry professionals network, listen to premier keynote speakers and explore the more than 150 exhibiting businesses. The event brings together many of top-level individuals and businesses that are all working to advance the cannabis industry while increasing its visibility on a global scale.To arrange one-on-one meetings with MCIG representatives at MJBizCon, contact paul@mciggroup.comAbout MCIG GroupHeadquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. employs a world-renowned tech team and has recently expanded its products and services to satisfy its evolving role in cannabis and hemp markets. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.Visit us on Facebook @ https://www.facebook.com/mCigInc/Follow us on Twitter @mcigIncForward-Looking StatementsThis press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact:mCig, Inc.Paul Rosenbergpaul@mciggroup.org

SOUTH ORANGE, NJ - (NewMediaWire) - October 14, 2019 - Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Daron Evans, President & CEO, will ring the Closing Bell. Where: Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio When: Monday, October 14, 2019 – 3:45 p.m. to 4:00 p.m. ET Social Media: For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit the Nasdaq Facebook page: https://www.facebook.com/Nasdaq/ For photos from ceremonies and events, please visit the Nasdaq Instagram page:https://www.instagram.com/nasdaq/ For live stream of ceremonies and events, please visit the Nasdaq YouTube page:https://www.youtube.com/nasdaq/live For news tweets, please visit the Nasdaq Twitter page:https://twitter.com/nasdaq For exciting viral content and ceremony photos, please visit the Nasdaq Tumblr page:https://nasdaq.tumblr.com/ Webcast:A live stream of the Nasdaq Closing Bell will be available at:https://livestream.com/nasdaq/liveor https://www.nasdaq.com/about/marketsitetowervideo.asx Photos:To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice. About Nephros, Inc. Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets. For more information about Nephros, please visit our website at www.nephros.com. About Nasdaq: Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 100 marketplaces in 50 countries. Nasdaq is home to approximately 4,000 total listings with a market value of approximately $14 trillion. To learn more, visit: http://business.nasdaq.com. Investor Relations Contacts: Kirin Smith, PresidentPCG Advisory, Inc.(646) 863-6519ksmith@pcgadvisory.com Andy Astor, COO & CFONephros, Inc.andy@nephros.com(201) 345-0824

Michelle Manu - (NewMediaWire) - October 13, 2019 - Burbank, CA – The Martial Arts History Museum’s media publishing company, Museum Productions, is proud to announce the release of their latest addition to their Biography Series, the “Biography of Lua Pioneer, Michelle Manu.” The art of Hawaiian Lua is a very unique and for many centuries, it has been a very secretive form of martial arts combat. From bone-breaking techniques, power grappling maneuvers to the influence of circular movements found in Hawaiian hula dancing, Lua was made more popular when King Kamehameha was a practitioner of the art in the 1700s. Famous for their shark-teeth weapons, Lua was only passed down from warrior to warrior and only a select few were taught the art. Olohe Solomon Kaihewalu was credited as the first individual to bring the artform to America in the early 1960s and the first instructor to teach the art to all who wanted to learn. One of his senior students was Kumu Michelle Manu. She is the first female practitioner in Lua history, to ever completely master the artform. Carrying on the traditions passed on by her teacher, she is not only responsible for bringing awareness to the art, but she has been entrusted with the knowledge and ability to create traditional, hand-made Lua weaponry. Manu, who was inducted into the prestigious Martial Arts History Museum’s Hall of Fame in 2016 for her pioneering accomplishments, has agreed to provide an insight into her life, the beginnings of her teachings and the launching of her women’s empowerment program called SHE (Super Hero Experience). The biography series produced by the Martial Arts History Museum, provides insight to each of the pioneers, champions, founders and significant individuals in martial arts history. Based on historical achievements and their impact on the world, these biographies play a crucial role in documenting martial arts history. “The Martial Arts History Museum is the only museum that has a permanent display of the history of Hawaiian Lua. Keeping this art alive in today’s society is a struggle and to carry on the teachings of Solomon Kaihewalu is indeed an honor. Michelle Manu is without a doubt, one of the most gifted individuals and perhaps the biggest advocate of the art today,” says museum president Michael Matsuda. Information about the Martial Arts History Museum can be found at http://www.mamuseum.com. To get your copy of Michelle Manu’s biography DVD, please visit https://www.amazon.com/Biography-Michelle-William-Christopher-Ford/dp/B07YTCDXYY/ref=sr_1_3?keywords=michelle+manu&qid=1570991889&sr=8-3 The Martial Arts History Museum is a non-profit 501(c)(3) organization and donations are accepted.

New York, NY - (NewMediaWire) - October 13, 2019 - Global Arena Holding, Inc. (the “Company”) (OTC PINK: GAHC), announced today, the company has completed its Annual Meeting of Stockholders (the “Annual Meeting”) on October 11, 2019 with its proposals receiving majority support from its shareholders. The three proposals, (1) re-appoint the Board of Directors, John S. Matthews, Facundo Bacardi and Martin Doane, (2) authorization to increase the authorized capital stock to 2 Billion, and (3) to ratify the appointment of Raul Carrega, CPA as the Company’s independent public accounting firm for the year ended December 31, 2019, were all accepted by the majority of Company’s shareholders during the Annual Meeting. “I am pleased with the results of the Annual Meeting as it demonstrates our shareholders’ approval of the Company’s current direction and trajectory,” said John S. Matthews, CEO. “Over the next few weeks the Company will update its shareholders on the completion of the acquisition of assets of Elections Services Solutions, the continuing development of election technology for registration and tabulation with our technology partners HCAS Technologies, Voting Portals, LLC, and Blockchain Valley Ventures of Zug, Switzerland, our new joint venture with TrueVote Inc., and the development of GAHI Acquisition Corp. Thanks to our very supportive shareholders, both the Board and management will continue working diligently to build the Company’s overall value.”The proposal to increase the authorized shares was a paramount decision that the Company’s shareholders made. It gives the Company the ability to push forward with the endeavor’s management believes will positively impact the growth of the Company.Mr. Matthews concluded, “I’d like to thank our shareholders for their vote of confidence in giving us the ability to continue building the Company in a manner we believe will be the most beneficial to future value of the Company. We will continue striving to be the best in our marketplace; both innovative and fundamentally sound in our business plan.”The Annual Meeting process was supported by: Clear Trust LLC, Broadridge, Mediant and Laurel Hill Advisory Group.About Global Arena Holding Global Arena Holding, Inc. trades on the OTC Pink Sheets under the ticker symbol GAHC. The Company has been publicly traded since 2011 and holds a number of interests, including Global Elections Services, Inc. and GAHI Acquisition Corp. The Company focuses on acquiring technologies, patents and companies having the ability to leverage the blockchain crypto technology.For more information visit: http://globalarenaholding.comSafe Harbor StatementThe Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release contains statements that are forward-looking, such as statements related to the future anticipated direction of the industry, plans for future expansion, various business development activities, planned or required capital expenditures, future funding sources, anticipated sales growth, and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by, or on behalf of, the company. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financing activities, domestic and global economic conditions, and other risks and uncertainties described in the Company's periodic filings with the Securities and Exchange Commission.CONTACT: Global Arena Holding, Inc. 208 East 51stStreet Suite 112 New York, NY 10022 kathryn@globalarenaholding.com Tel: 646-801-5524 www.globalarenaholding.com

NEW YORK, NY - (NewMediaWire) - October 12, 2019 - Faruqi (2) that there was an "untenable" imbalance of risk sharing between the Company and the joint venture project owners; (3) that, as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.On July 29, 2019, after the market closed, the Company disclosed that second quarter 2019 financial results were negatively impacted by non-cash charges related to four legacy, unconsolidated heavy civil joint venture projects.On this news, Granite's stock fell from $44.47 on July 29, 2019 to $36.49 on July 30, 2019-a $7.98 or 17.94% drop.On August 2, 2019, before the market opened, the Company announced its second quarter 2019 financial results, reporting revenue of $789.5 million, including $114.2 million in revenue reduction due to the charges disclosed earlier that week.On this news, Granite's stock fell from $34.00 on August 1, 2019 to $31.22 on August 2, 2019-a $2.78 or 8.18% drop.The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Granite's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner

NEW YORK, NY - (NewMediaWire) - October 12, 2019 - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Pluralsight, Inc. (NASDAQ: PS) ("Pluralsight" or the "Company") of the October 15, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.If you invested in Pluralsight stock or options between August 2, 2018 and July 31, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/PS. There is no cost or obligation to you.You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail torgonnello@faruqilaw.com.CONTACT:FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. rgonnello@faruqilaw.com Telephone: (877) 247-4292 or (212) 983-9330The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Pluralsight common stock between August 2, 2018 and July 31, 2019 (the "Class Period"). The case, City of Birmingham Firemen's and Policemen's Supplemental Pension System v. Pluralsight, Inc. et al., No. 19-cv-07563 was filed on August 13, 2019. The Company completed its initial public offering ("IPO") in May 2018, whereby it sold 23.8 million shares at a price of $15.00 per share. Less than a year later, Pluralsight completed a secondary public offering ("SPO") on March 6, 2019, whereby it sold 15.6 million shares at a price of $29.25 per share, for gross proceeds of over $450 million.The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the SPO that it was behind schedule onboarding new sales representatives, which was hurting the Company's sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.On July 31, 2019, after market close, Pluralsight announced disappointing financial results for the second quarter ended June 30, 2019, and that its billings growth rate had sharply deteriorated from over 40% to just 23% year-over-year. The Company blamed its declining growth in billings on sales execution challenges and other issues with its salesforce. Pluralsight also disclosed that its Chief Revenue Officer was resigning.On this news, Pluralsight's share price fell from $30.69 per share on July 31, 2019 to a closing price of $18.56 on August 1, 2019: a $12.13 or a 39.52% drop.The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Pluralsight's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.